Pages that link to "Q73048806"

The following pages link to The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate (Q73048806):

Displaying 18 items.

• Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence (Q24595863) (← links)
• Alcoholic liver disease: pathogenesis, management, and novel targets for therapy (Q26861620) (← links)
• A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problems (Q28072735) (← links)
• Acamprosate: A Review of Its Use in Alcohol Dependence (Q28263633) (← links)
• Therapy for alcoholic liver disease (Q28658193) (← links)
• Is there evidence for effectiveness of acamprosate in maintaining abstinence in alcohol dependent patients? (Q34363586) (← links)
• LAT software induced savings on medical costs of alcohol addicts' care--results from a matched-pairs case-control study (Q34472874) (← links)
• Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients (Q34982934) (← links)
• The current economic burden of cirrhosis. (Q35691411) (← links)
• Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility (Q35752035) (← links)
• Acamprosate: a new tool in the battle against alcohol dependence (Q37166144) (← links)
• Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy (Q37457307) (← links)
• Alcoholic liver disease: pathogenesis and new targets for therapy (Q37913987) (← links)
• Economic evaluation of alcoholism treatment. (Q40317236) (← links)
• Modelling lifetime QALYs and health care costs from different drinking patterns over time: a Markov model. (Q43053095) (← links)
• Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates (Q46570806) (← links)
• Alcoholic liver disease (Q51764048) (← links)
• Estimating Long-Term Drinking Patterns for People with Lifetime Alcohol Use Disorder (Q90452923) (← links)